The NOVELTY Scientific Community brings together the Scientific Committee, the National Principal Investigators and the AstraZeneca science and evidence leads. The Scientific Community is led by Co-Chairs, two external experts: Prof. Helen Reddel and Prof. Alberto Papi, joined by AstraZeneca Co-Chair: Dr Hana Müllerová.
Research proposals are primarily discussed and delivered through WorkStreams aligned around key research themes for the NOVELTY study, described below. Although each WorkStream has its own focus, there is collaboration across WorkStreams in the investigation of research questions that encompass or integrate more than one of these areas.